Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEVOCARNITINE vs LEVODOPA: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LEVOCARNITINE vs LEVODOPA: Safety Overview

Metric LEVOCARNITINE LEVODOPA
Total FAERS Reports 392 6,610
Deaths Reported 91 546
Death Rate 23.2% 8.3%
Hospitalizations 183 729
Average Patient Age 40.9 yrs 69.3 yrs
% Female Patients 52.6% 42.9%
FDA Approval Date Apr 10, 1986 Approved Prior to Jan 1, 1982
Manufacturer Saptalis Pharmaceuticals, LLC Deseret Biologicals, Inc.
Route ORAL ORAL
Marketing Status Prescription Discontinued